|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/12 | |
| C12N 7/00 |
| (11) | Number of the document | 2968515 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14717940.2 |
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/026570 |
| Date | 2014-03-13 |
| (87) | Number | WO 2014/151855 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361784122 P | 2013-03-14 | US |
| (72) |
STINCHCOMB, Dan T., US
LIVENGOOD, Jill A., US
VARGA, Laszlo, US
|
| (73) |
Takeda Vaccines, Inc.,
75 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS |
| COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS |